Stryker Corp.’s bid to acquire robotic surgical maker MAKO Surgical Corp. has the potential to disrupt the staid and predictable large joint industry where market share shifts between major suppliers typically can be measured in single-digits. But, with a $1.65 billion price tag, it also presents huge risks for the aggressively acquisitive Stryker.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?